Medpace Holdings (MEDP) Return on Capital Employed Growth (3y) (2019 - 2026)
Medpace Holdings (MEDP) Return on Capital Employed Growth (3y) (2019 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | -6.00 |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -193.00 |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 1,502.00 |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | -383.00 |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 95.00 |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 3,423.00 |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 10,000.00 |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | -158.00 |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 35.00 |
| 10 | Medpace Holdings | 16.54 Bn | 16.03 Bn | 201.64 Mn | 3,058.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3,058.00 |
| Mar 31, 2026 | 1,847.00 |
| Dec 31, 2025 | 5,087.00 |
| Sep 30, 2025 | 8,267.00 |
| Jun 30, 2025 | 4,122.00 |
| Mar 31, 2025 | 2,872.00 |
| Dec 31, 2024 | 2,652.00 |
| Sep 30, 2024 | 2,280.00 |
| Jun 30, 2024 | 2,473.00 |
| Mar 31, 2024 | 2,769.00 |
| Dec 31, 2023 | 3,360.00 |
| Sep 30, 2023 | 3,803.00 |
| Jun 30, 2023 | 4,244.00 |
| Mar 31, 2023 | 4,402.00 |
| Dec 31, 2022 | 3,526.00 |
| Sep 30, 2022 | 3,463.00 |
| Jun 30, 2022 | 3,508.00 |
| Mar 31, 2022 | 854.00 |
| Dec 31, 2021 | 432.00 |
| Sep 30, 2021 | 795.00 |